Amgen: Roche Drug Lurking In Shadows As Aranesp Grows Up
The trouble started in mid-October. That's when the price of Amgen Inc.'s shares, which had been at about $67, fell like autumn leaves, dipping just below $62 before an upsurge became evident in the first part of last week.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter